Detalhe da pesquisa
1.
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Hum Vaccin Immunother
; 19(2): 2240690, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37553178